Genzyme (GENZ)

Add a New Bulls Reason Company: Genzyme (GENZ) Current price: Headline: (100 character max) Analysis: Cancel 80% agree 5 votes   Market share leader for niche products Created when NASDAQ:GENZ was $64.10 | Edit | History Genzyme’s franchise products (Cerezyme, Renagel) continue to enjoy a majority market share in their niche markets, while new treatments (Myozyme, Synvisc) are being introduced in large, profitable markets. (100 character max) Cancel 100% agree 1 votes   GARP Top Contributor: H JK | Created when NASDAQ:GENZ was $49.16 | Edit | History This stock has taken quite a hit lately due to FDA inquiries about one of their major plants. Although this hurts the stock price now, most biotech companies are looked at with respect to pipeline. Near term earnings are very hard to forecast especially with biotech. This event is one of the reasons. It is also one of the reasons it looks attractive. (100 character max) Cancel 100% agree 1 votes   Lots of upcoming data releases Created when NASDAQ:GENZ was $64.10 | Edit | History 10 late-stage clinical trials of pipeline drugs will show data in the coming year, and successful results may buoy stock value. (100 character max) Cancel 100% agree 1 votes   Good late-stage pipeline Created when NASDAQ:GENZ was $64.10 | Edit | History Genzyme has a number of drugs awaiting foreign approval and should see increased revenue as these drugs expand into foreign markets. (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.